Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: A single-center experience

Liver Transplantation

Volumn 10, Issue 4, 2004, Pages 529-533

  Carey, Elizabeth J ^a   Douglas, David D ^a,b   Balan, Vijayan ^a   Vargas, Hugo E ^a   Byrne, Thomas J ^a   Moss, Adyr A ^a   Mulligan, David C ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; CADAVER DONOR; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; EXPERIENCE; FEMALE; HEPATOPULMONARY SYNDROME; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG ARTERIOVENOUS SHUNT; LUNG FUNCTION; MALE; OXYGEN THERAPY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; FEMALE; HEPATOPULMONARY SYNDROME; HUMANS; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 1842424644     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20127     Document Type: Article

References (23)

1. Battaglia SE, Pretto JJ, Irving LB, Jones RM, Angus PW. Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation. Hepatology 1997;25:1228-1232.
2. Martinez GP, Barbera JA, Visa J, Rimola A, Pare JC, Roca J, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001;34:651-657.
3. Stoller JK, Lange PA, Westveer MK, Carey WD, Vogt D, Henderson JM. Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation: The Cleveland Clinic experience. West J Med 1995;163:133-138.
4. Fallon MB, Abrams GA. Pulmonary dysfunction in chronic liver disease. Hepatology 2000;32:859-865.
5. Krowka MJ. Hepatopulmonary syndrome: Recent literature (1997 to 1999) and implications for liver transplantation. Liver Transpl 2000;6(Suppl 1):S31-S35.
6. Scott VL, Dodson SF, Kang Y. The hepatopulmonary syndrome. Surg Clin North Am 1999;79:23-41.
7. Collisson EA, Nourmand H, Fraiman MH, Cooper CB, Bellamy PE, Farmer DG, et al. Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. Liver Transpl 2002;8:925-931.
8. Kikuchi H, Ohkohchi N, Orii T, Satomi S. Living-related liver transplantation in patients with pulmonary vascular disease. Transplant Proc 2000;32:2177-2178.
9. Wade OL, Bishop JM. Cardiac Output and regional blood flow. Oxford: Blackwell Scientific; 1962.
10. Ueki J, Hughes JMB, Peters AM, Bellingan GJ, Mohammed MA, Dutton J, et al. Oxygen and 99mTc-MAA shunt estimations in patients with pulmonary arteriovenous malformations: Effects of changes in posture and lung volume. Thorax 1994;49:327-331.
11. Herve P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998;11:1153-1166.
12. Rolla G, Brussino L, Colagrande P, Scappaticci E, Morello M, Bergerone S, et al. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med 1998;129:375-378.
13. Luo B, Liu L, Tang L, Zhang J, Stockard CR, Grizzle WE, et al. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: A potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 2003;38:556-563.
14. Egawa H, Kasahara M, Inomata Y, Uemoto S, Asonuma K, Fujita S, et al. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 1999;67:712-717.
15. Krowka MJ, Porayko MK, Plevak DJ, Pappas SC, Steers JL, Krom RA, et al. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: Case reports and literature review. Mayo Clin Proc 1997;72:44-53.
16. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003;37:192-197.
17. Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VA, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375-1379.
18. Shiffman ML, Brown RS Jr, Olthoff KM, Everson G, Miller C, Siegler M, et al. Living donor liver transplantation: Summary of a conference at The National Institutes of Health. Liver Transpl 2002;8:174-188.
19. Trotter JF, Stolpman N, Wachs M, Bak T, Kugelmas M, Kam I, et al. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients. Liver Transpl 2002;8:212-218.
20. Gaglio PJ Sr, Malireddy S, Russo M, Lapointe-Rudow D, Emond JC, Brown RS Jr. Hepatitis C recurrence in recipients of grafts from living vs cadaveric liver donors [abstract]. Hepatology 2002;36:265A.
21. Taniguchi M, Wachs M, Bak T, Trotter J, Kugelmans M, Everson G, et al. Hepatitis C recurrence in living donor liver transplantation [abstract]. Am J Transplant 2002;2(Suppl 3):138.
22. Rodriguez-Luna H, Vargas HE, Sharma P, De Petris G, Ortiz J, Balan V, et al. Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci 2004;49:38-41.
23. Shiffman ML, Fisher RA, Stravitz T, Luketic VA, Sanyal AJ, Mills AS, et al. Histologic analysis of recurrent hepatitis C virus infection following living donor and cadaveric liver transplantation [abstract]. Am J Transplant 2003;3(S5):203.